Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Stem Cells
California Stem Cell Agency on Lacks: Informed Consent Cannot Remove All Questions
Posted: August 8, 2013 at 1:59 pm
(Photo and caption from the stem cell agency blog item this morning.) |
The $3 billion California stem cell
agency today weighed in on the Henrietta Lacks-NIH arrangement
restricting the use of her cell lines in research.
agency today weighed in on the Henrietta Lacks-NIH arrangement
restricting the use of her cell lines in research.
Writing on the agency's blog, Geoff
Lomax, the agency's senior officer for its standards group, noted
that the DNA sequence of her cell line was published without the
knowledge of her descendants. Lomax said,
Lomax, the agency's senior officer for its standards group, noted
that the DNA sequence of her cell line was published without the
knowledge of her descendants. Lomax said,
“The family was understandably upset
by the lack of consultation and in response the research team removed
the genome data from public access.”
Lomax continued,
“CIRM has benefited from these
efforts. We are currently supporting an initiative to collect tissue
samples from thousands of people with a range of incurable diseases
and create reprogrammed iPS cells from those tissues (here's
more about that initiative). These cells will be a resource for
scientists worldwide working to understand and treat diseases. Part
of this initiative includes a consent process to make sure people who
donate fully understand how their cells will be used. (This process
is formally called informed consent.)
“The informed
consent process includes a form that identifies the purposes of the
research and describes the way cells will be used. We are also
developing education materials that will help potential donors
quickly and easily understand the basic aspects of research that will
be conducted with those cells. The end result of this collaboration
with our grantees will be a process that is truly informative to
donors.
“The informed consent process can’t entirely
eliminate all future questions on the part of the donor, but it does
ensure that donors have a chance to understand how their cells will
be used and what information will be made public—something
Henrietta Lacks and her family never had.”
Posted in Stem Cells, Stem Cell Therapy
Comments Off on California Stem Cell Agency on Lacks: Informed Consent Cannot Remove All Questions
Skloots, Collins and More on Henrietta Lacks' Cell Line Deal
Posted: August 8, 2013 at 12:54 pm
More details about the unprecedented
arrangement involving Henrietta Lacks' cell line emerged today in a
wide range of publications, including a Nature journal piece that
said it was not a precedent.
arrangement involving Henrietta Lacks' cell line emerged today in a
wide range of publications, including a Nature journal piece that
said it was not a precedent.
The article was co-authored by Francis
Collins, head of the NIH, and Kathy Hudson, deputy director for
science, outreach and policy at the NIH.
Collins, head of the NIH, and Kathy Hudson, deputy director for
science, outreach and policy at the NIH.
“It is important to note, however,
that we are responding to an extraordinary situation here, not
setting a precedent for research with previously stored,
de-identified specimens. The approach we have developed through
working with the Lacks family is unique because HeLa cells were taken
and used without consent, and gave rise to the most widely used human
cell line in the world, and because the family members are known by
name to millions of people.”
The restrictions on use of the cell
lines came about after a flap erupted about their recent use without
the knowledge of her descendants. (The California Stem Cell Report carried a commentary on it yesterday.) Rebecca Skloots, author of the
best-seller, “The Immortal Life of Henrietta Lacks,” wrote about
the controversy in a March 23 op-ed piece in the New York Times. She
said,
lines came about after a flap erupted about their recent use without
the knowledge of her descendants. (The California Stem Cell Report carried a commentary on it yesterday.) Rebecca Skloots, author of the
best-seller, “The Immortal Life of Henrietta Lacks,” wrote about
the controversy in a March 23 op-ed piece in the New York Times. She
said,
In the article, Skloots said,
“Imagine if someone secretly sent
samples of your DNA to one of many companies that promise to tell you
what your genes say about you. That report would list the good news
(you’ll probably live to be 100) and the not-so-good news (you’ll
most likely develop Alzheimer’s, bipolar disorder and maybe
alcoholism). Now imagine they posted your genetic information online,
with your name on it. Some people may not mind. But I assure you,
many do: genetic information can be stigmatizing, and while it’s
illegal for employers or health insurance providers to discriminate
based on that information, this is not true for life insurance,
disability coverage or long-term care.
“'That is private family
information,” said Jeri Lacks-Whye, Lacks’s granddaughter. “It
shouldn’t have been published without our consent.'”
Nature also carried a Q&A with Collins in which he said,
“This has wrapped in it science,
scientific history, ethical concerns, the bringing together of people
of very different cultures, a family with all the complications that
families have.”
In the Wall Street Journal this
morning, Ron Winslow described the arrangement with the NIH like
this.
morning, Ron Winslow described the arrangement with the NIH like
this.
“Under the pact, two descendants of
Ms. Lacks will serve on a six-member panel with scientists to review
proposals from researchers seeking to sequence the DNA of cell lines
derived from her tumor or to use DNA profiles of such cells in their
research. That gives family members a highly unusual voice in who
gets access to personal health information.
Terms call for controlled access to the
genomic data and credit to the Lacks family in papers and scientific
presentations based on the research done with the DNA data.”
In an interview in The Scientist,
Skloots, who was involved in the Lacks-NIH negotiations, said the
Lacks family asked for her participation.
Skloots, who was involved in the Lacks-NIH negotiations, said the
Lacks family asked for her participation.
“The only reason I was involved in
this is because scientists did this without the family’s consent
and then it got all of this press coverage, and no one asked the
question, 'Did the family give consent?' So I sort of waded back
in.”
She continued,
“That OpEd that I
wrote was the first time I’d ever publicly expressed an opinion,
which was, 'Really?!? Are we going to continue to not ask the Lacks
family questions?' I was kind of shocked in a sense that nobody
thought to raise that issue.”
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Skloots, Collins and More on Henrietta Lacks' Cell Line Deal
The Henrietta Lacks Story and Eggs, Money and Motherhood
Posted: August 7, 2013 at 8:56 pm
The legacy of Henrietta Lacks popped up
again today in a piece in the New York Times that should
resonate among stem cell researchers and within the stem cell
industry.
again today in a piece in the New York Times that should
resonate among stem cell researchers and within the stem cell
industry.
It even has a current hook involving
California legislation to permit women to sell their eggs for the
purposes of scientific research – a bill that is now on the desk of
Gov. Jerry Brown.
California legislation to permit women to sell their eggs for the
purposes of scientific research – a bill that is now on the desk of
Gov. Jerry Brown.
The issues in the Lacks saga involve ownership of human
cells, trafficking in them and informed consent, all of which surface in one form or another in the state legislation.
cells, trafficking in them and informed consent, all of which surface in one form or another in the state legislation.
But first a refresher on Henrietta
Lacks. She was an African-American woman who died in 1951 of cervical
cancer at the age of 31. Shortly before her death, physicians removed
some of her tumor cells, and, as recounted in today's NYTimes article
by Carl Zimmer,
Lacks. She was an African-American woman who died in 1951 of cervical
cancer at the age of 31. Shortly before her death, physicians removed
some of her tumor cells, and, as recounted in today's NYTimes article
by Carl Zimmer,
“They later discovered that the cells
could thrive in a lab, a feat no human cells had achieved before.
"Soon the cells — nicknamed HeLa cells
— were being shipped from Baltimore around the world. In the 62
years since — twice as long as Ms. Lacks’s own brief life — her
cells have been the subject of more than 74,000 studies, many of
which have yielded profound insights into cell biology, vaccines, in
vitro fertilization and cancer.”
But Lacks never consented to her cells'
being studied, a situation not uncommon at the time, nor did her
family know about the situation until 1973. The complete story was
chronicled in 2010 in a best-selling book, “The Immortal Life of
Henrietta Lacks," by Rebecca Skloot.
being studied, a situation not uncommon at the time, nor did her
family know about the situation until 1973. The complete story was
chronicled in 2010 in a best-selling book, “The Immortal Life of
Henrietta Lacks," by Rebecca Skloot.
Zimmer noted in today's article,
“For 62 years, (Lacks') family has
been left out of the decision-making about that research. Now, over
the past four months, the National
Institutes of Health has come to an agreement with the Lacks
family to grant them control over how Henrietta Lacks’s genome is
used.”
The particulars involving her genome
are in Zimmer's story. But the article implicitly raises anew
questions that make many scientists uncomfortable. Often they contend
that the situation involving Lacks could not occur today because of
higher ethical standards. Standards ARE higher today. But problems
continue to arise in the scientific community, including the sale a few years ago of willed body parts at UCLA for $1.5 million to private medical companies.
are in Zimmer's story. But the article implicitly raises anew
questions that make many scientists uncomfortable. Often they contend
that the situation involving Lacks could not occur today because of
higher ethical standards. Standards ARE higher today. But problems
continue to arise in the scientific community, including the sale a few years ago of willed body parts at UCLA for $1.5 million to private medical companies.
Development of products based on human
stem cells promises even greater rewards, with billion-dollar
blockbuster therapies not out of the range of possibilities. Profit
and the desire to record a stunning research triumph are powerful
motivators. They can lead to short cuts and dubious practices, such
as seen in the Korean stem cell scandals of 2006.
stem cells promises even greater rewards, with billion-dollar
blockbuster therapies not out of the range of possibilities. Profit
and the desire to record a stunning research triumph are powerful
motivators. They can lead to short cuts and dubious practices, such
as seen in the Korean stem cell scandals of 2006.
So we come to whether women who donate
their eggs for stem cell research can give truly informed consent
when they surrender all rights to whatever products may result from
parts of their bodies, as is common on such consent agreements. Or
for that matter, what about the men who give up adult cells for
reprogramming to a pluripotent state? Can they really understand the
likelihood of a billion dollar product being generated with the help
of their contribution? On the other hand, can the donors also truly
understand that they are probably more likely to be struck by
lightning than have their body parts result in a medical blockbuster?
their eggs for stem cell research can give truly informed consent
when they surrender all rights to whatever products may result from
parts of their bodies, as is common on such consent agreements. Or
for that matter, what about the men who give up adult cells for
reprogramming to a pluripotent state? Can they really understand the
likelihood of a billion dollar product being generated with the help
of their contribution? On the other hand, can the donors also truly
understand that they are probably more likely to be struck by
lightning than have their body parts result in a medical blockbuster?
These considerations may seem
insignificant to some in science. But to grasp their full
implications, one only has to read a few of the nearly 200 reader
comments today on Zimmer's article today. Here is a sample.
insignificant to some in science. But to grasp their full
implications, one only has to read a few of the nearly 200 reader
comments today on Zimmer's article today. Here is a sample.
From Frank Spencer-Molloy in
Connecticut:
Connecticut:
“(T)the Lacks family was robbed.
Scores of companies profited to the tune of tens of millions of
dollars from products they made derived from Henrietta Lacks'
cancerous cells. Maybe this will provide some impetus to a wider
consideration of the rights patients are entitled to when their
tissues are cloned and disseminated to other researchers and
ultimately put to use in profit-making ventures.”
From Robbie in New York City:
“At the very least, this family needs
to be financially compensated for the anguish of their discovery and
for the time and energy they've put into pursuing their rights. In my
opinion, they also deserve a portion of any commercial gain that's
been made using the HeLa cells. It is only through having to give
away money that the powerful learn manners.”
From Julia Himmel in New York City:
“It is absolutely true that
scientists have had a blind spot when it came to the human element of
the HeLa cells.”
The pay-for-eggs legislation (AB926)
now before Gov. Brown requires informed consent from those who
provide eggs. Opponents of the measure, however, argue that truly
informed consent from some women could be actually impossible because
of economic pressures felt by the women. Writing in The Sacramento Bee last month, Diane Tober and Nancy Scheper-Hughes said,
now before Gov. Brown requires informed consent from those who
provide eggs. Opponents of the measure, however, argue that truly
informed consent from some women could be actually impossible because
of economic pressures felt by the women. Writing in The Sacramento Bee last month, Diane Tober and Nancy Scheper-Hughes said,
“Allowing a market in eggs for
research would reach beyond the current pool to target women who may
be motivated by dire need. How many low-income women might consider
selling their eggs, multiple times, to feed their children or pay the
rent?”
Even the fertility industry group
sponsoring the legislation acknowledges that informed consent can be
problematic. A 2012 news release from the American Society for
Reproductive Medicine said,
sponsoring the legislation acknowledges that informed consent can be
problematic. A 2012 news release from the American Society for
Reproductive Medicine said,
“Prospective egg donors must
assimilate a great deal of information in the informed consent
process, yet it remains difficult to determine the extent of their
actual understanding of egg donation and its potential risks.”
The story of the treatment of Henrietta
Lacks and her descendants is a poor commentary on science and
medicine. Yet it resonates with the public, which is keenly sensitive
to scientific and medical abuses, even in situations that did not
appear to be abuses at the time.
Lacks and her descendants is a poor commentary on science and
medicine. Yet it resonates with the public, which is keenly sensitive
to scientific and medical abuses, even in situations that did not
appear to be abuses at the time.
Stem cell research already is burdened by its own
particular moral and religious baggage. With
commercialization of new, pluripotent stem cell therapies coming ever
closer, the last thing the field needs is contemporary version of the
Lacks affair. It would behoove researchers and the stem cell industry
to walk with more than normal care as they manipulate products that
are tied inextricably to visions of both motherhood and money.
particular moral and religious baggage. With
commercialization of new, pluripotent stem cell therapies coming ever
closer, the last thing the field needs is contemporary version of the
Lacks affair. It would behoove researchers and the stem cell industry
to walk with more than normal care as they manipulate products that
are tied inextricably to visions of both motherhood and money.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/oncdCzO4V18/the-henrietta-lacks-story-and-eggs.html
Posted in Stem Cells, Stem Cell Therapy
Comments Off on The Henrietta Lacks Story and Eggs, Money and Motherhood
Gum Tissue Stem Cells Heal Fast And Fight Inflammation
Posted: August 7, 2013 at 3:49 pm
August 6, 2013
April Flowers for redOrbit.com Your Universe Online
A new study from the Ostrow School of Dentistry of the University of Southern California (USC) reveals stem cells found in mouth tissue can relieve inflammatory disease, as well as become other types of cells.
The study, published in a recent issue of the Journal of Dental Research, focused on gingival mesenchymal stem cells (GMSC) that are found in the gingival, or gum tissue, of the mouth. Like other stem cells, GMSC have the ability to develop into different types of cells as well as affect the immune system.
Gingiva is very unique in our body, says Professor Songtao Shi, associate professor at the Center for Craniofacial Molecular Biology. It has much less inflammatory reaction and heals much faster when compared to skin.
Before this study, the developmental origins and abilities of GMSC had not been fully demonstrated. The USC researchers reveal there are two types of GMSC. The first type, M-GMSC, arrives from the mesoderm layer of cells during embryonic development. The second type, N-GMSC, originate from cranial neural crest cells that develop into many important structures of the head and face. N-GMSC were found to comprise 90 percent of the gingival stem cells.
M-GMSC and N-GMSC vary dramatically in their abilities, the team found. In addition to being easier to change into other types of cells, including neural and cartilage-producing cells, N-GMSC also have more of a healing effect on inflammatory disease than M-GMSC. When mice with dextrate sulfate sodium-induced colitis an inflamed condition of the colon received transplants of N-GMSC, the inflammation was dramatically reduced.
The study findings suggest the stem cells in the gingiva obtained via a simple biopsy of the gums may have important medical applications in the future.
We will further work on dissecting the details of the gingiva stem cells, especially their notable immunoregulatory property, says Xingtian Xu, specialized lab technician at the Ostrow School of Dentistry Center for Craniofacial Molecular Biology.
Through the study of this unique oral tissue, we want to shed the light on the translational applications for improving skin wound healing and reducing scar formation.
See original here:
Gum Tissue Stem Cells Heal Fast And Fight Inflammation
Posted in Stem Cells
Comments Off on Gum Tissue Stem Cells Heal Fast And Fight Inflammation
Californians Top List of Stem Cell Honorees
Posted: August 7, 2013 at 9:44 am
Californians dominated the list of those to be honored at the World Stem Cell Summit coming up in San
Diego this December.
Diego this December.
They include fellow blogger Paul
Knoepfler, a stem cell scientist at UC Davis, and Roman Reed, the San Francisco Bay Area stem cell activist and son of another stem cell advocate, Don Reed. Both are among the 2013 Stem Cell Action Award honorees for this
year.
Knoepfler, a stem cell scientist at UC Davis, and Roman Reed, the San Francisco Bay Area stem cell activist and son of another stem cell advocate, Don Reed. Both are among the 2013 Stem Cell Action Award honorees for this
year.
Others include Denny Sanford, a
philanthropist whose name now adorns the Sanford-Burnham Institute in
La Jolla, and Malin Burnham, who is also linked to the institute.
Also being honored is Mary Ann Liebert, whose firm publishes
peer-reviewed journals in science and biomedical research.
philanthropist whose name now adorns the Sanford-Burnham Institute in
La Jolla, and Malin Burnham, who is also linked to the institute.
Also being honored is Mary Ann Liebert, whose firm publishes
peer-reviewed journals in science and biomedical research.
Malin is a San Diego businessman who
joined with an anonymous donor in 1996 to contribute $10 million to
the La Jolla Cancer Foundation. It was renamed to reflect that
contribution. In 2010, Sanford pledged $50 million to the
organization, and it was renamed again.
joined with an anonymous donor in 1996 to contribute $10 million to
the La Jolla Cancer Foundation. It was renamed to reflect that
contribution. In 2010, Sanford pledged $50 million to the
organization, and it was renamed again.
Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/1ThJSyU8BBU/californians-top-list-of-stem-cell.html
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Californians Top List of Stem Cell Honorees
UTEP student works to eradicate leukemia through stem cells
Posted: August 6, 2013 at 11:51 am
Through research, attention to detail and patience, Rebecca Soto is working to eradicate leukemia through stem cell research.
Soto, a junior at the University of Texas at El Paso, is one of 44 undergraduate students chosen from a pool of 650 applicants to participate in the 2013 Harvard Stem Cell Institute Internship program in Cambridge, Mass.
It was through her work at UTEP, in which she was studying the influenza virus through the Harvard Hughes Medical Institute, that Soto as given the opportunity to participate in the stem cell research program at Harvard. Soto said she jumped at the opportunity because of her love for science and the potential of stem cells.
"Stem cell research has been seen as the best potential to cure a variety of diseases," Soto said. "With leukemia the most typical type of treatments are bone marrow transplants. But sometimes the patient's immune system rejects the transplant. But if you can harvest the stem cells from the patient and reprogram their cells to be healthy they may be able to recuperate from the disease they have."
The summer program, hosted by Harvard University and 11 of the university's affiliated schools and hospitals including the Boston Children's Hospital, is a summer internship program in which college students study the promise of stem cell research and develop possible treatments
The program, which began June 10 and will end Aug. 16, gives undergraduate students hands on experience in the field of stem cell biology. The program also provides students with a stipend of $4,320.
Stem cells are biological cells that have the potential to renew themselves. Their use has been researched to renew or repair damaged tissue or organs.
"Stem cells are very promising," Soto said. "And the great thing about stem cell research is that it's not just limited to one field.
It can apply to a variety of different fields. I think that anyone that would be affected by a disease or serious illness could use stem cells to cure diseases and eradicate the pain that our loved ones may feel."
The 10-week program, began in 2004, with a small pool of applicants strictly from Harvard University, said William Lensch, the internship program director for the institute.
Go here to see the original:
UTEP student works to eradicate leukemia through stem cells
Posted in Stem Cells
Comments Off on UTEP student works to eradicate leukemia through stem cells
Scientists cook, eat beef made from cattle stem cells grown in lab
Posted: August 6, 2013 at 11:51 am
August 5, 2013, 8:29 a.m.
For a $330,000 burger, taste testers thought the flavor fell a little flat.
The hefty price tag, however, wasn't for some fancy, rare cut of meat. In fact, this meat had never so much as mooed in a previous life: It was beef grown in a laboratory.
Dutch scientists Monday unveiled their ambitious research project, years in the making, with a public taste test of their cultured beef in London.
Volunteer tasters sampled hamburger made from the lab-grown beef made from stem cells. Scientists hope it can one day alleviate a food crisis as the world's population swells and help combat climate change.
Quiz: How well do you know fast food?
To make the meat, scientists atMaastricht University in the Netherlandsused muscle stem cells from two organic cows and combined them with a nutrient solution. The muscle cells then grew into strands of meat. It takes 20,000 strands to make a 5-ounce burger.
Taste testers said the meat lacked the fat of a conventional burger, making the taste a little underwhelming, the Associated Press reported.
But with a bit more tinkering, Mark Post, who led the project, said that could be resolved.
Visit link:
Scientists cook, eat beef made from cattle stem cells grown in lab
Posted in Stem Cells
Comments Off on Scientists cook, eat beef made from cattle stem cells grown in lab
Burger grown from cow stem cells in laboratory put to taste test in London
Posted: August 6, 2013 at 11:50 am
LONDON For $332,000, you might expect a burger to come with fries and a shake.
But it's no ordinary hamburger that two volunteer taste-testers tucked into in London on Monday. The meat was grown in a laboratory, from cattle stem cells.
The perfectly round patty was pan fried in sunflower oil and butter and then sampled by Josh Schonwald, author of The Taste of Tomorrow, and food scientist Hanni Rutzler.
It was "close to meat," according to Rutzler, but she said she expected it to be softer and as the petri-dish beef contains no fat, it wasn't very juicy.
Schonwald also noted the absence of fat, which translated into a lesser flavor, "but the bite feels like a conventional hamburger"
Mark Post, whose team at Maastricht University in the Netherlands developed the burger, hopes that making meat in labs could eventually help feed the world and fight climate change.
Monday's taste test, coming after five years of research, is a key step toward making lab meat a culinary phenomenon.
"For the burger to succeed it has to look, feel and taste like the real thing," Post said.
Post and colleagues made the meat from the muscle cells of two organic cows. The cells were put into a nutrient solution to help them develop into muscle tissue, growing into small strands of meat.
It took nearly 20,000 strands to make one 5-ounce patty, which for Monday's taste test was seasoned with salt, egg powder, breadcrumbs, red beet juice and saffron. The project cost $332,000.
Go here to see the original:
Burger grown from cow stem cells in laboratory put to taste test in London
Posted in Stem Cells
Comments Off on Burger grown from cow stem cells in laboratory put to taste test in London
For $60,000, You Can Store Your Stem Cells in This Bank
Posted: August 6, 2013 at 11:50 am
French biotech entrepreneur Andre Choulika is working on an unusual and pricey project: A stem cell bank for adults. Choulika's stem cell bank, Sceil, is a new Singapore-based operation that claims to transform human skin cells into stem cells and then to store them for future medical procedures. For $60,000, clients can have a sample of their underarm skin punched at a local dermatologist, and sent to Singapore, where the cells are converted into stem cells over the course of a few months. The $60,000 only covers the first two years of storage.
Yes, it's expensive, but It's also one of the very first attempts to bank adult stem cells for future medical procedures.
Sceil, which operates in Singapore thanks to strict regulatory issues surrounding stem cell banking in the United States and the European Union, is based around the regenerative medicine theories of Nobel laureate Shinya Yamanaka. In a telephone conversation with Fast Company, Choulika expressed interest in future innovations--some decades away--that might come from Yamanaka's work. Yamanaka won his Nobel Prize, shared with researcher John Gurdon, for turning mature human cells into induced pluripotent stem cells. These stem cells, though somewhat more difficult to work with than embryonic stem cells, avoid much of the ethical and legal issues that surround them.
The process of converting underarm cells into stem cells takes several months, Choulika told me. Skin cell samples are cultured to a volume of several billion, and these primary cells are saved as backups. Then some of these cells are cultured and converted into induced pluripotent stem cells over a period of three to four months. The conversion process lasts longer for different people. In some people it's more difficult, and in others it's easier. For good measure, Choulika emphasized that his company stores the stem cells in liquid nitrogen on three different continents.
Here is an infographic Sceil provides to potential clients to explain his business model:
Three different continents? Right there is the rub with Sceil. The company's target audience are ultra-affluent folks with lots of spending money--although Choulika didn't say as much, the 12-14 million people worldwide he cited as a target market jibes nicely with that--who are worried about their future health. They could be a target market for some world-changing medical experiments in foreign countries.
Regenerative medicine researchers worldwide have promised revolutionary results. Researchers at Wake Forest University are applying regenerative medicine techniques to 3-D print artificial organs on demand. Scientists at San Francisco State University are working on regenerating adult teeth. Then there are the more experimental efforts attempting to undo neurological damage and human aging with regenerative medicine. Once the FDA and other regulatory agencies approve hospital-ready versions of these technologies decades from now, Fast Company readers under 50 may have a shot at organ donations-on-demand in their lifetimes.
For Choulika, the stem cell bank is an experimental effort. Since moving to France from Lebanon, he founded Cellectis, a genome engineering firm closely tied to the Pasteur Institute. Cellectis' bread and butter is the much more lucrative field of conventional gene editing and intellectual property licensing for everything from big pharma to companies that make genetically modified foods. Stem cell banking is still nascent, and Sceil will be one of the very first banks targeting adult stem cell donations.
Sceil's success comes down to those millions of people with $60,000 extra to spend. If the world has enough mega-rich people to spend tens of thousands of dollars on a future shot at growing a new pancreas or reversing aging by a decade, Sceil has pretty decent odds.
Read more here:
For $60,000, You Can Store Your Stem Cells in This Bank
Posted in Stem Cells
Comments Off on For $60,000, You Can Store Your Stem Cells in This Bank
Stem cells found in gum tissue may be best wound healers
Posted: August 6, 2013 at 11:50 am
Washington, Aug 06 (ANI): Stem cells found in mouth tissue have the ability to develop into different types of cells and can also relieve inflammatory disease, a new study has revealed.
The cells featured in the study by Ostrow School of Dentistry of USC were 'gingival mesenchymal' stem cells (GMSC), which are found in the gingiva, or gum tissue, within the mouth.
Professor Songtao Shi, the study's senior author said that gingiva has much less inflammatory reaction and heals much faster when compared to skin.
The study shows that there are two types of GMSC: those that arise from the mesoderm layer of cells during embryonic development (M-GMSC) and those that come from cranial neural crest cells (N-GMSC).
The cranial neural crest cells develop into many important structures of the head and face, and 90 percent of the gingival stem cells were found to be N-GMSC.
The two types of stem cells vary dramatically in their abilities. N-GMSC were not only easier to change into other types of cells, including neural and cartilage-producing cells; they also had much more of a healing effect on inflammatory disease than their counterparts.
When the N-GMSC were transplanted into mice with dextrate sulfate sodium-induced colitis - an inflamed condition of the colon - the inflammation was significantly reduced.
The study is published in the Journal of Dental Research. (ANI)
Go here to see the original:
Stem cells found in gum tissue may be best wound healers
Posted in Stem Cells
Comments Off on Stem cells found in gum tissue may be best wound healers